12 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)B-cell chronic lymphocytic leukemia, Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, B-Cell, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 32026-09-28NCT06073821
ASPIrin in Reducing Events in Dialysis ( ASPIRED )Chronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, urinary system disorderActive, not recruitingPhase 42026-09-14NCT04381143
Efficacy Analysis of Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Therapy in the Treatment of Chronic Subjective TinnitusChronic Subjective TinnitusNot yet recruitingNot applicable2026-08-31NCT07794462
Methotrexate Combined With Tofacitinib in Rheumatoid ArthritisSkin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritisRecruitingNot applicable2026-05-12NCT06301373
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerHR-positive, HER2-negative Breast NeoplasmsActive, not recruitingPhase 32026-01-07NCT05365178
A Randomized Controlled Study on the Improvement of Medical Experience for Patients With Radiation-induced Oropharyngeal Mucositis Based on the RIS System of the Internet of ThingsHead and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasmNot yet recruitingNot applicable2025-08-17NCT07126457
Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal MucositisHead and Neck Neoplasms, Neoplasms by Site, head and neck cancer, neoplasmRecruitingNot stated2025-07-16NCT06307327
Study of Porcine Fibrin Sealant in Preventing Cervical Anastomotic Leakage (PLACE030)Anastomotic Leak, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, digestive system neoplasm, esophageal disorder, neoplasmActive, not recruitingPhase 32025-06-12NCT03847857
A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast CancerNeoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 32025-06-10NCT05346224
Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiencyRecruitingNot stated2025-04-15NCT06926959
Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER)cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiencyNot yet recruitingNot applicable2024-02-05NCT06227286
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL ConstructionVentricular Outflow Obstruction, aortic valve disorder, aortic valve insufficiency, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorderRecruitingNot stated2023-10-12NCT06069232